RELATIONSHIP OF AGE WITH ELIGIBILITY FOR THROMBOLYTIC THERAPY AND MORTALITY AMONG PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION

Citation
Hm. Krumholz et al., RELATIONSHIP OF AGE WITH ELIGIBILITY FOR THROMBOLYTIC THERAPY AND MORTALITY AMONG PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Journal of the American Geriatrics Society, 42(2), 1994, pp. 127-131
Citations number
20
Categorie Soggetti
Geiatric & Gerontology","Geiatric & Gerontology
ISSN journal
00028614
Volume
42
Issue
2
Year of publication
1994
Pages
127 - 131
Database
ISI
SICI code
0002-8614(1994)42:2<127:ROAWEF>2.0.ZU;2-C
Abstract
Objective: To determine the relationship of age and the percentage of patients presenting to the emergency department with myocardial infarc tion who meet conventional electrocardiographic and time-to-presentati on criteria for thrombolytic therapy. Design: Prospective cohort study . Setting: Emergency departments of three university hospitals and fou r community hospitals. Patients: Patients enrolled in the Multicenter Chest Pain Study, an investigation of patients aged 30 years or older presenting to the emergency department with the chief complaint of ant erior, precordial, or left lateral chest pain unexplained by obvious l ocal trauma or abnormalities on the chest radiograph. Interventions: N one. Measurements: The frequency of patients who presented with conven tional electrocardiographic and time-to-presentation criteria for thro mbolysis. Main Results: Of a total of 12,140 patients who were enrolle d in the Multicenter Chest Pain Study, 10,850 had information about th eir electrocardiogram and their time-to-presentation. Acute myocardial infarction occurred in 1,584 patients, 746 of whom were over age 65. Among patients presenting to the emergency department with acute myoca rdial infarction, the proportion who arrived within 6 hours of the ons et of pain and had ST-segment elevation or pathologic Q-waves not know n to be old decreased significantly with increasing age, from 34% in p atients under 65 years to 18% for those 75 years and older. In additio n, comorbidities that would have contraindicated thrombolytic therapy were present in an additional 12% of myocardial infarction patients wh o were older than 65 years. Conclusion: Although other analyses have s hown that thrombolytic therapy is cost-effective for eligible elderly patients with acute myocardial infarction, only a small percentage of very elderly patients who present to the emergency department with acu te myocardial infarctions meet current eligibility criteria to receive it, so thrombolysis is unlikely to narrow the difference in mortality rates for young as compared with elderly patients with acute infarcti ons.